{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:40:22Z","timestamp":1770543622671,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study aimed to investigate the impact of nephrostomies on the outcome of total renal function (TRF) and split renal function (SRF) in patients with malignant pelvic tumors associated with upper urinary tract obstruction (UUTO).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with pelvic tumors suffering severe unilateral hydronephrosis treated at our hospital from 2000 to 2022 were included. Data for nephrostomy placement, short- and long-term renal function, and radiological and nuclear imaging studies were collected. The TRF and SRF of patients who underwent nephrostomy were compared to those who did not.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seven patients were included (rhabdomyosarcoma: 5, ovarian germ cell tumor: 1, malignant rhabdoid tumor: 1). Nephrostomies were placed in four, which were successfully managed without severe infections. Estimated glomerular filtration rate (eGFR) was significantly improved at the end of treatment in patients with nephrostomy. In contrast, eGFR in patients who did not undergo nephrostomy was not improved. Nuclear imaging studies (renograms or renal scintigrams) revealed impaired SRF of the affected kidney compared to the contralateral kidney, even in patients whose eGFR was within normal levels. Notably, SRF showed a trend to improve over time in one patient treated with nephrostomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Nephrostomy for UUTO caused by pelvic tumors may improve renal outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00383-024-05810-0","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:04:31Z","timestamp":1724051071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of emergent nephrostomy on long-term total and split renal function in patients with upper urinary tract obstruction due to pelvic malignant tumors"],"prefix":"10.1007","volume":"40","author":[{"given":"Katsuhiro","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunosuke","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoro","family":"Hishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"5810_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/end.1999.13.521","volume":"13","author":"MI Feng","year":"1999","unstructured":"Feng MI, Bellman GC, Shapiro CE (1999) Management of ureteral obstruction secondary to pelvic malignancies. J Endourol 13:521\u2013524. https:\/\/doi.org\/10.1089\/end.1999.13.521","journal-title":"J Endourol"},{"key":"5810_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/crad.2002.1114","volume":"57","author":"SV Chitale","year":"2002","unstructured":"Chitale SV, Scott-Barrett S, Ho ETS, Burgess NA (2002) The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 57:1118\u20131121. https:\/\/doi.org\/10.1053\/crad.2002.1114","journal-title":"Clin Radiol"},{"key":"5810_CR3","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.juro.2011.04.010","volume":"186","author":"A Alexander","year":"2011","unstructured":"Alexander A, Weber B, Lorenzo A et al (2011) Hydronephrosis in children with abdominal and pelvic neoplasms: outcome and survival analysis of a single center pediatric oncology series. J Urol 186:1705\u20131709. https:\/\/doi.org\/10.1016\/j.juro.2011.04.010","journal-title":"J Urol"},{"key":"5810_CR4","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/end.2006.0104","volume":"21","author":"E Aravantinos","year":"2007","unstructured":"Aravantinos E, Anagnostou T, Karatzas AD et al (2007) Percutaneous nephrostomy in patients with tumors of advanced stage: treatment dilemmas and impact on clinical course and quality of life. J Endourol 21:1297\u20131302. https:\/\/doi.org\/10.1089\/end.2006.0104","journal-title":"J Endourol"},{"key":"5810_CR5","first-page":"457","volume":"50","author":"T Tanaka","year":"2004","unstructured":"Tanaka T, Yanase M, Takatsuka K (2004) Clinical course in patients with percutaneous nephrostomy for hydronephrosis associated with advanced cancer. Hinyokika Kiyo 50:457\u2013462","journal-title":"Hinyokika Kiyo"},{"key":"5810_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.340","author":"M Shah","year":"2024","unstructured":"Shah M, Blest F, Blackmur J et al (2024) Malignant upper urinary tract obstruction in cancer patients: A systematic review. BJUI Compass. https:\/\/doi.org\/10.1002\/bco2.340","journal-title":"BJUI Compass"},{"key":"5810_CR7","first-page":"292","volume":"18","author":"P Sountoulides","year":"2014","unstructured":"Sountoulides P, Mykoniatis I, Dimasis N (2014) Palliative management of malignant upper urinary tract obstruction. Hippokratia 18:292\u2013297","journal-title":"Hippokratia"},{"key":"5810_CR8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.jpedsurg.2004.08.003","volume":"39","author":"DB Meir","year":"2004","unstructured":"Meir DB, Inoue M, Gur U et al (2004) Urinary diversion in children with pelvic tumors. J Pediatr Surg 39:1787\u20131790. https:\/\/doi.org\/10.1016\/j.jpedsurg.2004.08.003","journal-title":"J Pediatr Surg"},{"key":"5810_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpurol.2010.02.205","volume":"6","author":"HT Nguyen","year":"2010","unstructured":"Nguyen HT, Herndon CDA, Cooper C et al (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6:212\u2013231. https:\/\/doi.org\/10.1016\/j.jpurol.2010.02.205","journal-title":"J Pediatr Urol"},{"key":"5810_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K et al (2014) Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol 18:626\u2013633. https:\/\/doi.org\/10.1007\/s10157-013-0856-y","journal-title":"Clin Exp Nephrol"},{"key":"5810_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.juro.2012.08.094","volume":"189","author":"R Bahu","year":"2013","unstructured":"Bahu R, Chaftari A-M, Hachem RY et al (2013) Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol 189:130\u2013135. https:\/\/doi.org\/10.1016\/j.juro.2012.08.094","journal-title":"J Urol"},{"key":"5810_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jvir.2017.02.031","volume":"28","author":"JL McDevitt","year":"2017","unstructured":"McDevitt JL, Acosta-Torres S, Zhang N et al (2017) Long-term percutaneous nephrostomy management of malignant urinary obstruction: estimation of optimal exchange frequency and estimation of the financial impact of patient compliance. J Vasc Interv Radiol 28:1036-1042.e8. https:\/\/doi.org\/10.1016\/j.jvir.2017.02.031","journal-title":"J Vasc Interv Radiol"},{"key":"5810_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1055\/s-0031-1296085","volume":"28","author":"M Dagli","year":"2011","unstructured":"Dagli M, Ramchandani P (2011) Percutaneous nephrostomy: technical aspects and indications. Semin Intervent Radiol 28:424\u2013437. https:\/\/doi.org\/10.1055\/s-0031-1296085","journal-title":"Semin Intervent Radiol"},{"key":"5810_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s15010-018-1245-y","volume":"47","author":"AD Szvalb","year":"2019","unstructured":"Szvalb AD, El Haddad H, Rolston KV et al (2019) Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection 47:239\u2013245. https:\/\/doi.org\/10.1007\/s15010-018-1245-y","journal-title":"Infection"},{"key":"5810_CR15","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1007\/s00520-020-05662-z","volume":"28","author":"E Alma","year":"2020","unstructured":"Alma E, Ercil H, Vuruskan E et al (2020) Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction. Support Care Cancer 28:5581\u20135588. https:\/\/doi.org\/10.1007\/s00520-020-05662-z","journal-title":"Support Care Cancer"},{"key":"5810_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jvir.2010.07.018","volume":"21","author":"AM Venkatesan","year":"2010","unstructured":"Venkatesan AM, Kundu S, Sacks D et al (2010) Practice guideline for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol 21:1611\u20131630","journal-title":"J Vasc Interv Radiol"},{"key":"5810_CR17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1464-410X.2007.07172.x","volume":"100","author":"IG Jeong","year":"2007","unstructured":"Jeong IG, Han KS, Joung JY et al (2007) The outcome with ureteric stents for managing non-urological malignant ureteric obstruction. BJU Int 100:1288\u20131291. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07172.x","journal-title":"BJU Int"},{"key":"5810_CR18","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/01.ju.0000181807.56114.b7","volume":"174","author":"AM Ganatra","year":"2005","unstructured":"Ganatra AM, Loughlin KR (2005) The management of malignant ureteral obstruction treated with ureteral stents. J Urol 174:2125\u20132128. https:\/\/doi.org\/10.1097\/01.ju.0000181807.56114.b7","journal-title":"J Urol"},{"key":"5810_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/01.ju.0000130510.28768.f5","volume":"172","author":"SY Chung","year":"2004","unstructured":"Chung SY, Stein RJ, Landsittel D et al (2004) 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 172:592\u2013595. https:\/\/doi.org\/10.1097\/01.ju.0000130510.28768.f5","journal-title":"J Urol"},{"key":"5810_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4111\/kju.2013.54.5.316","volume":"54","author":"SH Yu","year":"2013","unstructured":"Yu SH, Ryu JG, Jeong SH et al (2013) Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents. Korean J Urol 54:316\u2013321. https:\/\/doi.org\/10.4111\/kju.2013.54.5.316","journal-title":"Korean J Urol"},{"key":"5810_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/RLU.0b013e3182443f68","volume":"37","author":"S Othman","year":"2012","unstructured":"Othman S, Al-Hawas A, Al-Maqtari R (2012) Renal cortical imaging in children: 99mTc MAG3 versus 99mTc DMSA. Clin Nucl Med 37:351\u2013355. https:\/\/doi.org\/10.1097\/RLU.0b013e3182443f68","journal-title":"Clin Nucl Med"},{"key":"5810_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4274\/jus.galenos.2019.3107","volume":"7","author":"F Demir","year":"2020","unstructured":"Demir F, Demir M (2020) Comparison of [. sup. 99m] Tc-DMSA,[. sup. 99m] Tc-DTPA and [. sup. 99m] Tc-MAG3 renal scintigraphy in the calculation of relative renal function\/rolatif renal fonksiyonunun hesaplanmasinda [. sup. 99m] Tc-DMSA,[. sup. 99m] Tc-DTPA ve [. sup. 99m] Tc-MAG3 renal sintigrafilerinin karsilastirilmasi. J Urol Surg 7:130\u2013134","journal-title":"J Urol Surg"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05810-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-024-05810-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05810-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:15:46Z","timestamp":1734023746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-024-05810-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5810"],"URL":"https:\/\/doi.org\/10.1007\/s00383-024-05810-0","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"7 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study design was approved by the Research Ethics Committee of Chiba University Graduate School of Medicine. The study was performed in accordance with the principles of the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Signed informed consent was waived, as this was a retrospective study using de-identified data. The details of the study were published on the institutional website, and individuals were guaranteed the right to decline participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"234"}}